- Ticker
- ACXP
- Price
- 2.04
- Stock movement up
- +0.03 (1.49%)
- Company name
- Acurx Pharmaceuticals LLC
- Exchange
- (NASDAQ ,
- Currency
- USD )
- Sector
- Healthcare >Biotechnology
- Market cap
- 32.32M
- Ent value
- 26.51M
- Price/Sales
- -
- Price/Book
- 5.39
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- -
- 1 year return
- 22.16%
- 3 year return
- -25.83%
- 5 year return
- -
- 10 year return
- -
Last updated: 2024-09-13
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
DIVIDENDS
ACXP does not pay dividends or no data was received
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | - |
| Price to Book | 5.39 |
| EV to Sales | - |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 15.84M |
| EPS (TTM) | -1.04 |
| FCF per share (TTM) | -0.71 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 0.00 |
| Gross profit (TTM) | 0.00 |
| Operating income (TTM) | -3.46B |
| Net income (TTM) | -16.05M |
| EPS (TTM) | -1.04 |
| EPS (1y forward) | -1.59 |
Margins
Loading...
Margins data
| Gross margin (TTM) | - |
| Operating margin (TTM) | - |
| Profit margin (TTM) | - |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 8.92M |
| Net receivables | 0.00 |
| Total current assets | 9.11M |
| Goodwill | 0.00 |
| Intangible assets | 0.00 |
| Property, plant and equipment | 0.00 |
| Total assets | 9.11M |
| Accounts payable | 3.11M |
| Short/Current long term debt | 0.00 |
| Total current liabilities | 3.11M |
| Total liabilities | 3.11M |
| Shareholder's equity | 6.00M |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | -10.93M |
| Capital expenditures (TTM) | 0.00 |
| Free cash flow (TTM) | -10.93M |
| Dividends paid (TTM) | 0.00 |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | -267.61% |
| Return on Assets | -176.23% |
| Return on Invested Capital | -267.61% |
| Cash Return on Invested Capital | -182.22% |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 2.08 |
| Daily high | 2.08 |
| Daily low | 2.00 |
| Daily Volume | 58K |
| All-time high | 7.89 |
| 1y analyst estimate | 11.66 |
| Beta | -1.70 |
| EPS (TTM) | -1.04 |
| Dividend per share | - |
| Ex-div date | - |
| Next earnings date | 12 Nov 2024 |
Downside potential
Loading...
Downside potential data
| ACXP | S&P500 | |
| Current price drop from All-time high | -74.14% | -0.50% |
| Highest price drop | -83.78% | -56.47% |
| Date of highest drop | 3 Oct 2023 | 9 Mar 2009 |
| Avg drop from high | -56.51% | -11.22% |
| Avg time to new high | 811 days | 12 days |
| Max time to new high | 810 days | 1805 days |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
COMPANY DETAILS
Marketcap
32.32M
Marketcap category
Small-cap
Description
Acurx Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops antibiotics to treat bacterial infections. The company's lead antibiotic candidate is ibezapolstat, a novel mechanism of action that targets the polymerase IIIC enzyme that is in Phase 2b clinical trial to treat patients with clostridium difficile infections. It also develops ACX-375C, a potential oral and parenteral treatment targeting gram-positive bacteria, including methicillin-resistant staphylococcus aureus, vancomycin-resistant enterococcus, and penicillin-resistant streptococcus pneumonia. Acurx Pharmaceuticals, Inc. was incorporated in 2017 and is headquartered in Staten Island, New York.
Employees
4
Website
Investor relations
-
SEC filings
CEO
Country
USA
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
Seeking AlphaPress releases
iO Charts is a Seeking Alpha partnerNext page